A clinicopathological observation of Nyssen-van Bogaert syndrome with second motor neuron degeneration: two distinct clinical entities.
OBJECTIVE
To report a novel clinicopathological observation of Nyssen-van Bogaert syndrome. To compare this observation with those previously reported. To discuss the nosological entity of this syndrome. To define the exact etiopathogenic mechanism of the neurogenic amyotrophy occurring at the late stage of the disease.


METHODS
The patient was a 16-year-old girl who developed loss of vision and deafness at the age of 8. Ataxia with slight cerebellar signs were present by the age of 14. Over the next 2 years, she developed distal weakness and wasting of the legs with depressed ankle reflexes. She died at the age of 16. Deparaffinized sections of the brain, the brain stem, the cerebellum and the spinal cord were stained with haematoxylin & eosin (H&E), Nissl, Woelcke, Bodian, periodic acid-schiff (PAS), Sudan Black and Kluver Barera. Antibodies anti-GFAP, anti-MPB and anti-neurofilaments were used for immunohistochemical stainings following the avidin-biotin-peroxydase complex (ABC) methods.


RESULTS
The clinical pictures in our patient are similar to those previously reported in juvenile patients with optico-cochleo-dentate syndrome. Pathological study of the nervous system confirmed the diagnosis of Nyssen-van Bogaert syndrome and also showed a severe anterior horn, posterior horn and Clarke's column nerve cell degeneration with anterior root atrophy.


CONCLUSIONS
From these clinical and pathological data, the authors suggest to include Nyssen-van Bogaert syndrome among the group of multiple system atrophy, propose to divide this syndrome into 2 forms (an early infantile form and a juvenile form) and consider that the neurogenic amyotrophy occurring at the late stage of the disease in juvenile and adult patients is mainly caused by the second motor neuron involvement.
Larnaout
A
A
Service de neurologie, Institute national de neurologie, Tunis, Tunisia.
Ben Hamida
M
M
Hentati
F
F
D000293:Adolescent; D001766:Blindness / Q000175:diagnosis; D001921:Brain / Q000473:pathology; D002524:Cerebellar Ataxia / Q000175:diagnosis; D003638:Deafness / Q000175:diagnosis; D003711:Demyelinating Diseases / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D005808:Genes, Recessive; D006651:Histocytochemistry; D006801:Humans; D016472:Motor Neuron Disease / Q000473:pathology*; D009410:Nerve Degeneration / Q000175:diagnosis*; D009896:Optic Atrophy / Q000175:diagnosis; D009929:Organ Size; D013116:Spinal Cord / Q000473:pathology; D013577:Syndrome